Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-21.6%/yr
Quarterly compound
Percentile
P83
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
3 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q3 2025 | 26.47% |
| Q2 2025 | 0.00% |
| Q1 2025 | -21.43% |
| Q4 2024 | -115.38% |
| Q3 2024 | 79.69% |
| Q2 2024 | -146.15% |
| Q1 2024 | -18.18% |
| Q4 2023 | -46.67% |
| Q3 2023 | -7.14% |
| Q2 2023 | 58.82% |
| Q1 2023 | -112.50% |
| Q4 2022 | 30.43% |
| Q3 2022 | 54.90% |
| Q2 2022 | 28.17% |
| Q1 2022 | 10.13% |
| Q4 2021 | -8.22% |
| Q3 2021 | 1.35% |
| Q2 2021 | 5.13% |
| Q1 2021 | -11.43% |
| Q4 2020 | 4.11% |
| Q3 2020 | -21.67% |
| Q2 2020 | 1.64% |
| Q1 2020 | -32.61% |
| Q4 2019 | -24.32% |
| Q3 2019 | -8.82% |
| Q2 2019 | -54.55% |
| Q1 2019 | -37.50% |
| Q4 2018 | -33.33% |
| Q3 2018 | 14.29% |
| Q2 2018 | 12.50% |
| Q1 2018 | 0.00% |